Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr;22(4):545-552.
doi: 10.1016/j.hpb.2019.08.012. Epub 2019 Sep 16.

Characteristics of atypical large well-differentiated hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma?

Affiliations

Characteristics of atypical large well-differentiated hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma?

Masayuki Okuno et al. HPB (Oxford). 2020 Apr.

Abstract

Background: Hepatocellular carcinoma (HCC) de-differentiation is thought to correlate with size, therefore well-differentiated HCC ≥3 cm are considered rare and not fully understood.

Methods: Patients who underwent hepatectomy for HCC between 1998-2016 were retrospectively analyzed. Patient's characteristics and recurrence-free (RFS) and overall (OS) survival were compared between those with atypical- (well-differentiated-HCC ≥3 cm) and typical-HCC (moderate-to-poorly-differentiated HCC ≥3 cm).

Results: Of 176 patients included in this study, 37 (21%) had atypical-HCC. Patients with atypical-HCC were less likely to be Asian ethnicity (3% vs. 17%, p = 0.062), have lower rate of viral infection (14% vs. 43%, p = 0.003), cirrhosis (8% vs. 27%, p = 0.015). The tumors were less likely to demonstrate vascular invasion (30% vs. 59%, p = 0.002), and were associated with a lower alpha-fetoprotein level (3.5 ng/ml vs. 33.2 ng/ml, p < 0.001). Patients with atypical-HCC had a longer RFS (5-y RFS: 58.3% vs. 35.7%, p = 0.016) and OS (5-y OS: 79.1% vs 53.3%, p = 0.029) as compared to those with typical-HCC following univariate analysis, however this did not appear following multivariate analysis.

Conclusion: Patients with atypical-HCC have different characteristic in terms of epidemiology, etiology, cirrhosis and vascular invasion as compared to typical-HCC. The etiology of atypical-HCC may be non-alcoholic fatty liver disease-related and/or malignant transformation of hepatocellular adenoma.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Progression process of hepatocellular carcinoma (HCC).
Typically, HCC develop from pre-neoplastic lesions (dysplastic nodule) to early HCC. Majority of early HCC consist of well-differentiated tissues, and then, de-differentiate to moderate-to-poor-differentiated HCC along with enlargement, which is called as “multistep progression”. Well-differentiated HCC beyond a diameter of 3 cm is considered to be rare and referred to as “atypical large well-differentiated HCC”., HBV, hepatitis B virus; HCV, hepatitis C virus; NAFLD, non-alcoholic fatty liver disease.
Fig. 2
Fig. 2
(a) Recurrence-free survival and (b) overall survival after hepatectomy according to the type of HCC.
Fig. 3
Fig. 3
(a) Recurrence-free survival and (b) overall survival after hepatectomy according to the type of HCC only in patients with stage I and II (TNM classification in AJCC 8th edition).

Similar articles

Cited by

References

    1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer. 2010;127(12):2893–2917. - PubMed
    1. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet (London, England). 2012;379(9822):1245–1255. - PubMed
    1. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 1954;7(3):462–503. - PubMed
    1. Nam SW, Park JY, Ramasamy A, et al. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling. Hepatology (Baltimore, Md). 2005;42(4):809–818. - PubMed
    1. Kudo M. Atypical large well-differentiated hepatocellular carcinoma with benign nature: a new clinical entity. Intervirology. 2004;47(3–5):227–237. - PubMed

Publication types